The Korea Times close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
Biz & Tech
  • Auto
  • IT
  • Game
  • Manufacturing
  • Retail & Food
  • Energy
  • Construction
  • Airlines
Finance
  • Policies
  • Economy
  • Markets
  • Banks
  • Non-banks
Opinion
  • Editorial
  • Columns
  • Thoughts of the Times
  • Cartoon
  • Today in History
  • Blogs
  • Tribune Service
  • Blondie & Garfield
  • Letter to the Editor
Lifestyle
  • Arts
  • Books
  • Travel & Cuisine
  • Trend
  • Fashion
  • Around Town
  • Fortune Telling
Entertainment
  • K-pop
  • K-dramas & Shows
  • Movies
  • Music
  • Performances
  • Asia Model Festival
Sports
  • Football
  • Golf
  • Baseball
  • Other Sports
World
  • Asia Pacific
  • Americas
  • Europe & Africa
  • SCMP
Video
  • On the Spot
  • Feature
  • News
Photos
  • Photo News
  • Darkroom
Community
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
  • The Korea Times
  • search
  • Site Map
  • E-paper
  • Subscribe
  • Register
  • LogIn
search close
National
  • Politics
  • Diplomacy
  • Defense
  • Labor & Environment
  • Law & Crime
  • Health & Welfare
  • Embassy
  • Seoul & Provinces
  • Education
  • Foreign Communities
  • Obituaries
Thu, February 25, 2021 | 23:26
Health & Welfare
Korea OKs use of AstraZeneca vaccine for all adults
Posted : 2021-02-10 16:18
Updated : 2021-02-11 08:39
Mail
Print Preview
Font Size Up
Font Size Down
Food and Drug Safety Minister Kim Gang-lip speaks during a press conference at the ministry in Cheongju, North Chungcheong Province, Wednesday, on the conditional approval of AstraZeneca's coronavirus vaccine for all age groups including people aged 65 or older. Yonhap
Food and Drug Safety Minister Kim Gang-lip speaks during a press conference at the ministry in Cheongju, North Chungcheong Province, Wednesday, on the conditional approval of AstraZeneca's coronavirus vaccine for all age groups including people aged 65 or older. Yonhap

By Bahk Eun-ji

The Ministry of Food and Drug Safety said Wednesday it has approved the use of the COVID-19 vaccine made by AstraZeneca for all adults despite lingering concerns over its efficacy and safety especially for the elderly,.

The decision is contrary to that made by a dozen other countries which have either not approved use of the vaccine from the British-Swedish pharmaceutical firm and Oxford University or have recommended against giving shots to people aged over 65.

Following the decision, anti-coronavirus inoculations are set to begin Feb. 26, with the AstraZeneca vaccine being the first to be administered before vaccines from other companies arrive.

The ministry said that it decided to approve the use of the AstraZeneca vaccine for adults aged over 18 on condition that the pharmaceutical company submits further data on clinical trials.

The decision was made at a third review by the ministry's panels of experts. Earlier in the first assessment, participants said it would be okay to administer the vaccine to adults of all ages, while the second review group concluded that further study of its efficacy and safety for senior citizens would be needed.

"The final review panel for the vaccine concluded that it is effective in the elderly, but use for senior citizens aged 65 or older should be carefully determined according to each person's health," Drug Safety Minister Kim Gang-lip said in a press briefing Wednesday.

With the approval, vaccinations will proceed according to the plan devised by the Korea Disease Control and Prevention Agency (KDCA).

The KDCA said it will begin by vaccinating 776,900 people including medical staff and elderly people at geriatric hospitals in the rest of first quarter. Many of the elderly here are thus likely to get the AstraZeneca vaccine.

The agency said it would finalize the list of vaccination recipients in the first quarter by Feb. 19. Exactly when to begin inoculations will be decided on later by its own panel of experts.

While the government here has given a positive response to the AstraZeneca vaccine, several countries have advised caution when vaccinating those over 65, mainly due to insufficient data on its safety for the elderly.

Regulators of a number of European countries including France, Germany, Sweden and Austria have questioned whether the vaccine from the company should be given to them at all ― the four decided to prioritize AstraZeneca use for those younger than 65.

Meanwhile, a survey of 1,068 adults conducted from Feb. 5 to 8 by Seoul National University's Graduate School of Public Health showed 56.8 percent of Koreans want to get the coronavirus vaccine sooner than the order that will be set by the government.

In a similar survey conducted by the school a month earlier, 67.7 percent of respondents answered that they would get the vaccine after checking on whether those getting the shots first were fine.

In the meantime, the KDCA said all Korean nationals arriving from abroad must submit a negative result from a polymerase chain reaction (PCR) coronavirus test before embarking for the country, starting from Feb. 24. Last month, the government mandated all foreign arrivals to submit negative PCR test results.

The toughened regulation came as the number of virus variant cases from the United Kingdom, Brazil and South Africa has been growing here.

Regardless of nationality, all arrivals should undergo a total of three diagnostic tests, one before departure, one immediately after entry and one before being released from the mandatory 14-day self-quarantine.


Emailejb@koreatimes.co.kr Article ListMore articles by this reporter









 
 
  • K League star Ki Sung-yueng denies sexual assault allegations
  • All overseas arrivals required to submit negative PCR test results
  • Haute couture designer Kay Kim speaks about SM's girl band debut costume, her brand
  • Korea reports 1st population decline in 2020; total fertility rate hits new record of 0.84
  • Victims still reeling from traumatic past, yet bullies forgetful
  • Earth is suffering [PHOTOS]
  • Hyundai to replace Kona EV batteries
  • [ANALYSIS] Is Samsung Electronics losing competence in NAND?
  • New virus cases rebound to over 400 ahead of vaccine rollout
  • South Korea raises wartime sex slavery issue at UN
  • B.A.P Himchan sentenced to 10 months in prison for sexual assault B.A.P Himchan sentenced to 10 months in prison for sexual assault
  • Agency refuses to confirm report that Jennie and G-Dragon are dating Agency refuses to confirm report that Jennie and G-Dragon are dating
  • [INTERVIEW] 'Minari' actor Han Ye-ri recalls why the film is special to her [INTERVIEW] 'Minari' actor Han Ye-ri recalls why the film is special to her
  • Online streamer under fire for 'thoughtless' behavior in Brazil Online streamer under fire for 'thoughtless' behavior in Brazil
  • 'Beauty Water' becomes 1st Korean animated film to win award at Boston Sci-Fi Film Festival 'Beauty Water' becomes 1st Korean animated film to win award at Boston Sci-Fi Film Festival
DARKROOM
  • Earth is suffering [PHOTOS]

    Earth is suffering [PHOTOS]

  • NASA's Perseverance rover is landing on Mars

    NASA's Perseverance rover is landing on Mars

  • Fun in the snow, sledding for everyone

    Fun in the snow, sledding for everyone

  • Our children deserve better: Part 3

    Our children deserve better: Part 3

  • Mass COVID-19 vaccination campaign starts: Part 2

    Mass COVID-19 vaccination campaign starts: Part 2

  • About Korea Times
  • CEO Message
  • Times History
  • Content Sales
  • Media Kit
  • Contact Us
  • Location
  • Privacy Statement
  • Terms of Service
  • Mobile Service
  • RSS Service
  • 고충처리인
  • hankookilbo
  • Dongwha Group
  • Code of Ethics
Copyright